In this compelling episode of the Parallax Podcast, host Dr Ankur Kalra sits down with Dr Janarthanan Sathananthan, an interventional and structural cardiologist and the Chief Medical Officer of Interventional Cardiology at Boston Scientific. Dr Sathananthan recounts his life's journey, from being born in Sri Lanka during the civil war, and moving to Zimbabwe, New Zealand, Canada, and finally North America. He shares how his diverse upbringing profoundly shaped his career in cardiology.
Together, Dr Kalra and Dr Sathananthan delve into cultural challenges and lessons learned from Dr Sathananthan’s father, a dentist who experienced significant discrimination throughout his career. They explore Dr Sathananthan's decision to pursue interventional cardiology, and his passion for the intersection of technology and medicine. This episode also delves into Dr Sathananthan's role as Chief Medical Officer at Boston Scientific, focusing on global initiatives to expand coronary therapies and the growth of PCI in the Asia-Pacific region. They also touch on the ongoing struggle to balance work and personal life in a demanding field.
Listeners are invited to submit questions and comments to podcast@radcliffe-group.com, which may be addressed by Dr Kalra in the next episode. Join us for this insightful conversation with Dr Janarthanan Sathananthan on the Parallax Podcast.
Guest: @J_Sathananthan
Host: @AnkurKalraMD
Produced by: @RadcliffeCARDIO
Tune in to discover the strategies that Dr. Kalra and Dr. Alasnag are currently employing and gain insights into how these data will shape their future decision-making in the catheterization laboratory. Don't miss this informative discussion at the forefront of interventional cardiology.
As we adapt to the changes brought about by the pandemic, Dr Singh outlines the necessary steps to foster a reality in which we can utilize these technologies to create more time for human connection.
Dr Owens is Medical Director of the Center for Inherited Cardiac Disease and Associate Professor of Medicine at the Hospital of the University of Pennsylvania.
This series is supported by an unrestricted educational grant from Bristol Myers Squibb. Please see www.camzyosrems.com for important safety information.
This content is intended for US-based physicians.
This series is supported by an unrestricted educational grant from Bristol Myers Squibb. Please see www.camzyosrems.com for important safety information.
This content is intended for US-based physicians.
This series is supported by an unrestricted educational grant from Bristol Myers Squibb. Please see www.camzyosrems.com for important safety information.
This content is intended for US-based physicians.
During her interventional cardiology fellowship, Dr Baron became fascinated by the implementation of novel technologies. She earned her degree in Clinical Epidemiology and spent a year working at the FDA’s Device Evaluation unit.
In 2019 Dr Baron presented the results of her late-breaking trial, COAPT. Ankur invites Suzanne to discuss the economic analysis of the study and to give a short introduction to cost-effectiveness analysis. Suzanne provides an overview of the trial and they talk about the importance of understanding the value and benefits of new devices from both the patient and the health-economic point of viewpoint.
How should you start building a research programme? What are Chuck Simonton’s thoughts on the relationship between doctors and the industry? What is Chuck’s message to young cardiologists?
After the #MedBikini campaign provoked by a misogynistic study that scrutinized female doctors’ social media posts, this episode is about creating a safer environment for female healthcare professionals.
The charity organisation, Women as One is an agent for women and men to be part of medicine that is built on talent, rather than a privilege. Roxana and Ankur discuss the role of mentorship and family-friendly work environment in mending the broken house of cardiology. Roxana talks about the practical tools that are available for women to take the next steps in their career and achieve their goals.
Dr Kalra asks Dr Mauri about early influences and her traineeship with legendary interventionalists, the late Donald Baim and Richard Kuntz. Dr Mauri talks openly about her decision-making process and the importance of selecting your priorities and committing to them. Ankur asks Laura about her decision to go into industry. Laura shares her thoughts on medical innovations and meeting urgent needs with unique perspectives.
What is Dr Mauri’s advice for a young cardiologist? How did she balance research and patient care? What are the questions that helped her decision making? How does Dr Mauri think about innovations in medicine?